gms | German Medical Science

42. Kongress der Deutschen Gesellschaft für Rheumatologie, 28. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie, 24. Wissenschaftliche Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie

17.-20. September 2014, Düsseldorf

Rheumatoid arthritis therapy – influence on results of reconstructive joints operations

Meeting Abstract

Search Medline for

  • L. Myasoutova - Kazan State Medical University, Kazan, Russia
  • Svetlana Lapshina - Kazan State Medical University, Kazan, Russia

Deutsche Gesellschaft für Rheumatologie. Deutsche Gesellschaft für Orthopädische Rheumatologie. Gesellschaft für Kinder- und Jugendrheumatologie. 42. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh); 28. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh); 24. wissenschaftliche Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR). Düsseldorf, 17.-20.09.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. DocRO.02

doi: 10.3205/14dgrh123, urn:nbn:de:0183-14dgrh1231

Published: September 12, 2014

© 2014 Myasoutova et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Background: To analyze the results of arthroplasty of the knee and hip joints, depending on the initial activity of the disease and received therapy .

Methods: Total hip and knee prosthesis was used on 48 RA patients (43 women, 5 men ), mean age 49,5 ± 15,8 years. High disease activity by DAS28 was observed in 13 patients (27.1% ), moderate - in 25 ( 52.1 %), the lowest - in 10 ( 20.8 %) patients.

At the time of surgery (before and after) 28 (58.3 % ) patients continued to receive DMARDs . 8 (16.6% ) patients received biologics, which were canceled before the operation in accordance with the terms specified in the national guidelines. 26 (54.1 %) patients received steroids, of which in combination with DMARDs - 9 (18.8% ). Before surgery and in 6 months postoperative period VAS ,DAS28, HAQ have been evaluated.

Results: Within 6 months after surgery VAS decreased at 30,9 ± 18,9 mm ( p < 0.05) , disease activity decreased (high - 5 ( 10.4 % ), moderate 21 (43.75 %) , the lowest -22 (45,8%)), HAQ index decreased from 1,68 ± 0,94 to 1,12 ± 0,73 ( p < 0.05).

VAS pain reduction in patients treated with corticosteroids alone (n = 17 ) was - 24,2 ± 18,2 mm , steroids + DMARD (n = 9 ) - 29,4 ± 18,9 mm, only DMARDs (n = 11) 34,2 ± 19,1 mm, biologics + DMARDs (n = 8 ) 39,1 ± 20,3 mm. DDAS28 did not depend on the received therapy.

Positive dynamics in relation to the functional capacity of patients in the group (n = 19) receiving DMARDs with or without biologics (DHAQ = -0,71 ± 0,32) compared with patients receiving steroids without basic therapy (n = 17 ) - DHAQ = -0,46 ± 0,32 was significantly (p < 0.05) higher.

Conclusion: Total joint replacement is an effective method to improve functional capacity, pain relief and can help to reduce the activity of RA. Functional capacity after surgery is higher in patients receiving DMARDs continuously or receiving biologics compared to patients receiving steroids.